A Randomized Trial of Early Conversion From Calcineurin Inhibitors (CNI) to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2019
At a glance
- Drugs Belatacept (Primary) ; Ciclosporin; Tacrolimus
- Indications Delayed graft function; Renal transplant rejection
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Sep 2014 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.
- 24 Sep 2014 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017 as reported by ClinicalTrials.gov record.